Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

ROXONIN 100/MG TAPE 7TAPES
- Sku : I-021627
Key features
Roxonin Tape Cutaneous patch 100mg 28 Pat is a cutaneous patch containing loxoprofen 100 mg. Loxoprofen is a prodrug converted to an active trans‑alcohol metabolite that inhibits COX‑1 and COX‑2, reducing prostaglandin synthesis to relieve local inflammation and pain. The patch is indicated for topical relief of pain and inflammation in musculoskeletal conditions such as osteoarthritis, soft‑tissue rheumatism (myalgia, tendinitis/periarthritis), and post‑traumatic pain or swelling from sprains, strains, and contusions. Available OTC as cutaneous patches in a pack of 28.- Brand: ROXONIN
- Active Ingredient: LOXOPROFEN 100mg
- Strength: 100mg
- Dosage Form: Cutaneous patch
- Pack Size: 28 Patches
- Route: Topical
- Prescription Status: OTC
- Drug Class: Topical NSAID (Non-Steroidal Anti-Inflammatory Drug) - Propionic acid derivative
- Manufacturer: LEAD CHEMICAL CO., LTD.
- Country of Origin: Japan
- SFDA Registration No.: 403269234
- Shelf Life: 36 months
- Storage: do not store above 25°c
- Pain Type: Muscular/Joint
- Nsaid: Yes
- Opioid: No
Indications
Approved Uses
Topical relief of pain and inflammation in musculoskeletal conditions such as osteoarthritis and soft-tissue rheumatism (e.g., myalgia, tendinitis/periarthritis), and post‑traumatic pain/swelling (e.g., sprains/strains/contusions).
Dosage & Administration
Dosing by Condition
Musculoskeletal pain and inflammation: Apply one 100mg patch to the affected area once or twice daily. Osteoarthritis/joint pain: Apply one patch to the affected joint once or twice daily
Initial Dose
One 100mg patch applied to the affected area once daily
Maintenance Dose
One 100mg patch applied once or twice daily to the affected area
Maximum Dose
Apply 1 patch to the affected area once daily; do not apply more than 1 patch in 24 hours.
How to Take
Apply to clean, dry, intact skin over the painful area; remove the release liner and press firmly to ensure full contact. Use one patch once daily (leave in place up to 24 hours) unless the local label directs otherwise. Do not apply to broken/irritated skin, mucous membranes, or near the eyes; avoid occlusive dressings/heat sources; wash hands after application and after removal.
Side Effects
Common Side Effects
Application-site reactions: pruritus, erythema, rash, irritation, and contact dermatitis; systemic NSAID-type adverse effects are uncommon but possible with extensive/prolonged use.
Side Effect Frequency
Common: application-site reactions (pruritus, erythema, rash/irritation, contact dermatitis); systemic GI effects (e.g., gastric discomfort) are uncommon/rare with topical use compared with oral NSAIDs.
Drug Interactions
Interaction Severity
Clinically significant interactions are generally LOW with topical use, but use CAUTION with concurrent systemic NSAIDs/aspirin (additive NSAID toxicity) and anticoagulants/antiplatelets (theoretical increased bleeding risk) if large-area/prolonged use; major systemic interactions (e.g., methotrexate, lithium) are primarily concerns with oral NSAIDs and are unlikely with standard topical exposure.
Food Interaction
None clinically relevant (topical product; food does not affect absorption).
Special Populations
Kidney Impairment
No specific dose adjustment for topical use; use with caution in renal impairment and avoid prolonged use/large surface area application in significant renal disease
Storage & Patient Advice
Stopping the Medicine
Safe to stop anytime; no tapering required
Pharmacology
Mechanism of Action
Loxoprofen is a prodrug converted to an active trans-alcohol metabolite that inhibits COX-1/COX-2, reducing prostaglandin synthesis and thereby decreasing local inflammation and pain.
Duration of Effect
Approximately 24 hours per patch (once-daily application).
Bioavailability
Systemic absorption is low with topical loxoprofen patches and systemic exposure is substantially lower than with oral dosing; exact bioavailability varies and is not reliably stated as a single percentage.
Metabolism
Hepatic/extrahepatic reduction of the prodrug to the active trans-alcohol metabolite primarily via carbonyl reductase; CYP-mediated metabolism is not the primary activation pathway.
Product Information
Available Dosage Forms
For this SFDA-registered product: cutaneous patch (tape) only.
Composition per Dose
Each patch: 100mg loxoprofen sodium hydrate
OTC Alternatives
Topical diclofenac gel, topical ibuprofen gel, topical ketoprofen gel
Pain Type
Muscular/Joint
Nsaid
Yes
Opioid
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)


